Published in Blood Weekly, February 24th, 2000
Children with stage III or IV neuroblastoma (NB) commonly are treated with surgery, chemotherapy, and stem cell rescue. Gene marking studies have demonstrated that reinfusion of autologous stem cells contaminated with a level of tumor cells that is undetectable morphologically contributes to relapse, Meck and colleagues noted.
Meck et al. reported that they are developing a method to eliminate NB cells from stem cell preparations. They presented their research at the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.